Form 4: Cardiff Lexington CFO Receives Series I Preferred Stock as Compensation

Matthew T. Shafer, CFO of Cardiff Lexington Corp, received 5,000 shares of Series I Preferred Stock as partial compensation for his services.

Summary

• On January 31, 2024, Matthew T. Shafer, the Chief Financial Officer of Cardiff Lexington Corp, received 5,000 shares of Series I Preferred Stock.
• This stock was granted as partial compensation for his services.
• Each share of Series I Preferred Stock is convertible into common stock.
• The conversion rate depends on the closing market price of the common stock.
• If the common stock price is less than $4.00 per share, each preferred share converts into a number of common shares equal to two times the stated value ($4.00 per share) divided by the closing market price.
• If the common stock price is equal to or greater than $4.00 per share, each preferred share converts into two common shares.
• The Series I Preferred Stock has no expiration date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of executive compensation. The impact depends on the investor's view of the company's prospects and the CFO's role.

Positives

• The CFO's compensation includes equity, aligning his interests with those of the shareholders.
• The conversion terms of the preferred stock could provide upside potential if the common stock price increases.

Risks

• The value of the preferred stock is dependent on the performance of the common stock.
• The conversion terms could be less favorable if the common stock price remains low.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This announcement is a routine disclosure of executive compensation in the form of equity. It's common for companies, especially smaller ones, to use stock options or preferred stock as part of their compensation packages to conserve cash and align management's interests with shareholders.

Comparison to Industry Standards

• Equity compensation is a standard practice across various industries, particularly in growth-oriented companies.
• Comparing the specific terms of the Series I Preferred Stock (conversion ratio, valuation) to similar instruments used by comparable companies in the same sector (e.g., other small-cap healthcare or technology firms) would provide a more detailed assessment of its competitiveness.
• Companies like Novavax, Sorrento Therapeutics, and Ocugen, which are also in the healthcare sector and have similar market capitalizations, often use stock options and restricted stock units as part of their executive compensation packages.

Stakeholder Impact

• Shareholders may view this as a positive sign that the CFO's interests are aligned with theirs.
• Employees may see this as a standard compensation practice.
• The impact on customers, suppliers, and creditors is likely minimal.

Key Dates